Glucagon-like peptide-2 and its therapeutic use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 23, 1999
Grant Date -
N/A
app pub date -
Apr 14, 1995
filing date -
Apr 14, 1995
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Glucagon-like peptide 2, a product of glucagon gene expression, has been identified as a gastrointestinal tissue growth factor. Its effects on the growth of small intestine and on pancreatic islets are described. Its formulation as a pharmaceutical, and its therapeutic use in treating bowel tissue disorders and in treating diabetes, are described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully